Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Funder

Showing results (261-270 of 356) with videos related to

Pageof 36
Sort By:
Molecular Endocrinology (Baltimore, Md.)|August 26, 1998
Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteinsC Logie, M Nichols, K Myles, et al.
Molecular and Cellular Endocrinology|February 1, 1985
Kallikrein gene expression in the rat anterior pituitaryP J Fuller, J A Clements, P L Whitfeld, et al.
The Journal of Endocrinology|March 1, 1986
Pregnancy-associated changes in ovarian immunoreactive beta-endorphin in ratsD J Autelitano, S J Lolait, A I Smith, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive ratsJ S Hutchinson, R Di Nicolantonio, A Lim, et al.
Endocrinology|July 1, 1986
Estrogen regulation of kallikrein gene expression in the rat anterior pituitaryJ A Clements, P J Fuller, M McNally, et al.
Neuroendocrinology|November 1, 1988
Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemiaD Engler, T Pham, M J Fullerton, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1981
Immunoreactive beta-endorphin levels in plasma and pituitary tissue from genetically hypertensive and normotensive ratsJ S Hutchinson, A Lim, R DiNicolantonio, et al.
Circulation Research|June 1, 1980
Toward more specific aldosterone antagonists. A radioreceptor assay approachJ W Funder, J E Mercer, S Ulick, et al.
Oncogene|December 22, 1999
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitroH Li, Y Cao, M C Berndt, et al.
The International Journal of Biochemistry & Cell Biology|January 30, 1999
Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropesH Li, P J Robinson, S Kawashima, et al.
Pageof 36

Showing results (261-270 of 356) with videos related to

Sort By:
Pageof 36
Molecular Endocrinology (Baltimore, Md.)|August 26, 1998
Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteinsC Logie, M Nichols, K Myles, et al.
Molecular and Cellular Endocrinology|February 1, 1985
Kallikrein gene expression in the rat anterior pituitaryP J Fuller, J A Clements, P L Whitfeld, et al.
The Journal of Endocrinology|March 1, 1986
Pregnancy-associated changes in ovarian immunoreactive beta-endorphin in ratsD J Autelitano, S J Lolait, A I Smith, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive ratsJ S Hutchinson, R Di Nicolantonio, A Lim, et al.
Endocrinology|July 1, 1986
Estrogen regulation of kallikrein gene expression in the rat anterior pituitaryJ A Clements, P J Fuller, M McNally, et al.
Neuroendocrinology|November 1, 1988
Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemiaD Engler, T Pham, M J Fullerton, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1981
Immunoreactive beta-endorphin levels in plasma and pituitary tissue from genetically hypertensive and normotensive ratsJ S Hutchinson, A Lim, R DiNicolantonio, et al.
Circulation Research|June 1, 1980
Toward more specific aldosterone antagonists. A radioreceptor assay approachJ W Funder, J E Mercer, S Ulick, et al.
Oncogene|December 22, 1999
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitroH Li, Y Cao, M C Berndt, et al.
The International Journal of Biochemistry & Cell Biology|January 30, 1999
Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropesH Li, P J Robinson, S Kawashima, et al.
Pageof 36